News

Blackbaud Finalizes Sale of EVERFI to Private Investment Firm

Blackbaud Finalizes Sale of EVERFI to Private Investment Firm

Blackbaud Completes Sale of EVERFI

Blackbaud, Inc. (NASDAQ: BLKB), a leading software company that prioritizes social impact, has finalized the sale of its EVERFI business. This decision aligns with Blackbaud's ongoing focus on its core services and strategic objectives.

Financial Overview and Strategic Review

The sale, which was made to a private investment firm, is set against the backdrop of a thorough strategic review by Blackbaud. The company generated an impressive $1.15 billion in revenue over the past twelve months, maintaining a strong gross profit margin of 55.2%. Dale Strange, the president of corporate impact at Blackbaud, emphasized their commitment to ensuring a seamless transition for EVERFI's customers and employees.

Commitment to Customer Support

As Strange noted, EVERFI will continue to deliver vital educational courses covering topics such as financial literacy and workplace training. This commitment underscores Blackbaud's dedication to supporting social initiatives even after the sale.

Blackbaud's Core Offerings and Future Plans

Post-transaction, Blackbaud will retain its YourCause portfolio and Impact Edge solution, both crucial for corporate giving and engagement. These services reinforce the company's stance on enabling businesses to expand their social impact.

Acknowledged Contributions to Social Impact

Blackbaud has received numerous accolades for its contributions to social responsibility, including recognition from Newsweek and Forbes. Operating in multiple countries, the company excels in remote-first operations, allowing it to support users globally.

Recent Performance Insights

Despite the sale, recent analysis indicates expected net income growth and share buybacks by management. Additionally, Blackbaud reported a noncash impairment charge of approximately $415 million for the EVERFI asset group due to underperformance, which prompted a reassessment of business alternatives.

Revenue Growth and Guidance Updates

In the Third Quarter of 2024, Blackbaud experienced a 6.6% increase in overall revenue and a moderate 6.8% rise in contractual recurring revenue. However, they noted a significant 26% decline in revenue from the EVERFI segment, leading to an updated annual revenue guidance of $1.150 billion to $1.160 billion.

Analyst Reactions and Stock Outlook

Analysts at Baird have revised their outlook for Blackbaud, downgrading the stock from Outperform to Neutral. They also reduced the price target to $80 from $92, a shift influenced by a general reset in growth expectations and the updated perspective on Blackbaud's core social sector.

Future Strategic Directions

Looking ahead, Blackbaud plans to offload the underperforming EVERFI segment, with Goldman Sachs advising on potential strategic options. The company remains committed to its stock repurchase initiative, aiming to buy back up to 10% of its common stock by the end of the year.

Frequently Asked Questions

What is the recent sale related to Blackbaud?

Blackbaud has completed the sale of its EVERFI business to a private investment firm, focusing on its core offerings.

How did Blackbaud perform financially recently?

In the last year, Blackbaud generated $1.15 billion in revenue and reported a 6.6% increase overall, despite challenges in its EVERFI segment.

What recognition has Blackbaud received?

Blackbaud has been named among America's Most Responsible Companies and America's Best Employers, highlighting its social impact contributions.

What are Blackbaud's future plans post-sale?

Blackbaud plans to focus on its remaining services and engage in stock repurchase strategies while exploring strategic options for the EVERFI segment.

How is Blackbaud's stock being viewed by analysts?

Analysts have recently downgraded Blackbaud's stock from Outperform to Neutral, adjusting the price target based on new growth expectations.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 194

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 96

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Chime Joins S&P MidCap 400 Amid Merger Jostle

Updated Category News Views 194

Index Shake-Up: Who's In, Who's Out? Hold onto your hats, folks—big changes are coming to the S&P MidCap 400! Chime Financial Inc. is crashing the party, taking a seat at the table, as NorthWestern Energy Group gets the boot. Now, if that doesn’t grab your attention, I don’t know what will. You've got to appreciate the chaos and opportunities that come with a roster...

Continue Reading
IEHP's Wellness Center Launch Faces Delay in California

Updated Category News Views 104

Unexpected Delay for IEHP's Community Hub Straight outta Rancho Cucamonga, we've got some news that'll have folks in San Bernardino holding their breath a little longer. The Inland Empire Health Plan (or IEHP if you're part of the 1.4 million served by them) had folks pumped for their new Community Wellness Center. But guess what? They had to slam the brakes on the grand...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 222

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 168

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 138

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 201

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Dana Concludes Tender Offers for Senior Notes

Updated Category News Views 130

An Investor's Glance at Dana's Strategic Moves Dana Incorporated (NYSE: DAN) just pulled a bold move with their tender offers, snapping up a hefty $357,873,000 in outstanding principal on their senior notes. This isn’t just pocket change; folks holding out for securities can feel the tension of watching big numbers get shuffled around. You gotta wonder, what's the play...

Continue Reading

Top 5 Most Recently Viewed Articles

Carvana Integrates Auction-IRC Megasite in Atlanta Area

Updated Category News Views 150

Carvana's Exciting New Megasite Integration in Atlanta Carvana Co. (NYSE: CVNA), a leading online platform for buying and selling used cars, has made an announcement that showcases its commitment to innovation and growth. The company is integrating an auction and reconditioning 'Megasite' in the Atlanta area. This strategic move aims to enhance operational efficiency...

Continue Reading
Skyflow Introduces Enhanced Security Layer for Agentic AI

Updated Category News Views 201

Skyflow's Approach to Agentic AI Security Skyflow has emerged as a leader in the realm of data security and privacy, especially within the rapidly evolving landscape of artificial intelligence. The company has recently unveiled exciting enhancements to its Agentic AI offerings. These advancements are designed to allow businesses to deploy AI agents while ensuring robust...

Continue Reading
Bladex Achieves Impressive Financial Growth in Q3 2025 Results

Updated Category News Views 213

Bladex Reports Remarkable Financial Performance Bladex has announced impressive financial results for the third quarter of 2025, highlighting exceptional growth in its Commercial Portfolio, which surged to US$10.9 billion, reflecting a 12% increase year-over-year. Additionally, total deposits reached US$6.8 billion, a significant 21% growth compared to the previous year....

Continue Reading
First Trust Advisors L.P. Distributes Monthly ETF Earnings

Updated Category News Views 119

First Trust Advisors L.P. Announces ETF Distributions First Trust Advisors L.P. (FTA) has declared its monthly distributions for various exchange-traded funds. This announcement brings exciting news for investors as FTA continues to showcase its commitment to providing transparent and regular distributions. Important Distribution Dates In connection with the recent...

Continue Reading
Tungsten Prices Surge: Almonty Industries Weighs Future Trends

Updated Category News Views 402

A New Dawn for Tungsten Pricing Forget the old narratives; tungsten is strutting its stuff like never before. Almonty Industries Inc. (NASDAQ:ALM) is at the forefront—CEO Lewis Black sat down recently to chat with Benzinga, and his insights really hit home. We're staring down a supply squeeze like nothing we've seen before, echoing through both Eastern and Western...

Continue Reading